Search alternatives:
systemic decrease » systemic disease (Expand Search), systemic diseases (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » a decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
12 we » 12 wt (Expand Search), 1_ we (Expand Search), 16 we (Expand Search)
systemic decrease » systemic disease (Expand Search), systemic diseases (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » a decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
12 we » 12 wt (Expand Search), 1_ we (Expand Search), 16 we (Expand Search)
-
1
Decreases in Colonic and Systemic Inflammation in Chronic HIV Infection after IL-7 Administration
Published 2014“…Plasma levels of sCD14 and D-dimer, indicative of systemic inflammation, decreased after r-hIL-7. Increases of colonic mucosal T-cells correlated strongly with the decreased systemic levels of sCD14, the LPS coreceptor - a marker of monocyte activation. …”
-
2
DataSheet1_Knockdown of Ift88 in fibroblasts causes extracellular matrix remodeling and decreases conduction velocity in cardiomyocyte monolayers.docx
Published 2022“…Conduction velocity (CV) was significantly decreased in the siIft88 group in comparison to siNC [11.12 ± 4.27 cm/s (n = 10) vs. 17.00 ± 6.20 (n = 10) respectively, p < 0.05]. …”
-
3
-
4
-
5
-
6
Presentation_1_Regulatory B Cells Are Decreased and Impaired in Their Function in Peripheral Maternal Blood in Pre-term Birth.PPTX
Published 2020“…Interferences in the fine-tuned balance of the maternal immune system have been pointed to as one possible cause of PTB. …”
-
7
-
8
-
9
Supplementary Material for: Decreased Systemic Levels of Endocan-1 and CXCL16 in Psoriasis Are Restored following Narrowband UVB Treatment
Published 2018“…<b><i>Results:</i></b> We identified the mediators endocan-1, CXCL16, and sVEGFR1, which were systemically decreased in psoriasis at baseline, as well as FABP3, FABP4, and sIL-1R1, which showed normal baseline levels. …”
-
10
-
11
-
12
-
13
-
14
-
15
The time constant for reacidification decreases with rising action potential number.
Published 2014Subjects: -
16
Evidence That p-Cresol and IL-6 Are Adsorbed by the HFR Cartridge: Towards a New Strategy to Decrease Systemic Inflammation in Dialyzed Patients?
Published 2014“…</p><p>Methods</p><p>We compared the levels of IL-6 and p-cresol in ultrafiltrate samples collected at the inlet (UF<sub>in</sub>) and at the outlet (UF<sub>out</sub>) of the cartridge at the start or at the end of a 240 min HFR session in 12 inflamed chronic HD patients. …”
-
17
Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg
Published 2024“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
-
18
Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg
Published 2024“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
-
19
Image5_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg
Published 2024“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
-
20
Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg
Published 2024“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”